Viewing Study NCT01386411



Ignite Creation Date: 2024-05-05 @ 11:39 PM
Last Modification Date: 2024-10-26 @ 10:37 AM
Study NCT ID: NCT01386411
Status: COMPLETED
Last Update Posted: 2017-11-08
First Post: 2011-06-29

Brief Title: Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Study Overview

Official Title: Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer
Status: COMPLETED
Status Verified Date: 2017-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Genes are the blueprints for our bodies Some people are born with an abnormal copy mutation of a gene These people may have a higher chance of getting a disease Different mutations in different genes cause different diseases Some women get breast cancer because they are born with an abnormal copy of a gene called BRCA1 or BRCA2 These women also have a higher chance of getting ovary cancer Women with breast cancer and an abnormal copy of BRCA1 or BRCA2 also have a higher chance of getting a second breast cancer in their other breast Because of this women who might have a mutation may have genetic testing soon after their breast cancer diagnosis to learn about their risks of getting another cancer

Genetic testing may be done right after a woman has been diagnosed with breast cancer It may also be done later after surgery is done to treat the cancer The investigators do not know when it is best to do genetic testing The investigators are doing this study to try to understand whether women prefer testing before or after surgery The investigator also want to find out how they feel about their choice later on when their diagnosis in more in their past
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None